ロード中...

Biomarkers in phase I–II chemoprevention trials: lessons from the NCI experience

Early phase clinical trials are an essential component of chemopreventive drug development to identify signals of drug efficacy that can subsequently be explored definitively in phase III trials. Whereas phase I trials focus on safety and identification of optimal dose and schedule for cancer preven...

詳細記述

保存先:
書誌詳細
出版年:Ecancermedicalscience
第一著者: Szabo, Eva
フォーマット: Artigo
言語:Inglês
出版事項: Cancer Intelligence 2015
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4664504/
https://ncbi.nlm.nih.gov/pubmed/26635903
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2015.599
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!